CytomX Therapeutics, Inc. Share Price
NASDAQ: CTMXHealthcare
Live CytomX Therapeutics, Inc. Share Price Chart
O H L
CytomX Therapeutics, Inc. Performance Overview
Days Range
▼
$2.78Low
$2.82High
Markets Today
| Previous Close | $2.82 |
|---|---|
| Open | $2.82 |
| Volume | 570,392 |
| Day's Range | $2.78 - $2.82 |
| 52W Range | $1.93 - $8.21 |
| Market Cap | $602.49 M |
Historical Performance
| 1M Returns | -16.81 |
|---|---|
| 3M Returns | -4.41 |
| 6M Returns | -35.91 |
| 1Y Returns | +38.24 |
| 5Y Returns | -46.08 |
| 10Y Returns | -82.52 |
CytomX Therapeutics, Inc. Fundamentals
| Market Cap | $602.49 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $76.20 M |
| ROE TTM | -0.41 |
| EPS TTM | $-0.46 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.99 |
| EBITDA | $-20.99 M |
| Profit Margin | -26.73 |
| Market Cap | $602.49 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $76.20 M |
| ROE TTM | -0.41 |
| EPS TTM | $-0.46 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.99 |
| EBITDA | $-20.99 M |
| Profit Margin | -26.73 |
CytomX Therapeutics, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $50.92 M | $18.66 M | $5.96 M | $663.00 K | $10.26 M | $1.42 M |
| Gross Profit + | $50.92 M | $18.66 M | $5.96 M | $663.00 K | $10.26 M | $1.42 M |
| Operating Income | $22.62 M | -$1.29 M | -$15.77 M | -$27.93 M | -$19.67 M | -$23.78 M |
| EBITDA | $23.01 M | -$939.00 K | -$15.63 M | -$27.42 M | -$19.42 M | -$23.73 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $385.00 K | $347.00 K | $134.00 K | $510.00 K | $251.00 K | $47.00 K |
| Income Before Tax | $23.59 M | -$91.00 K | -$14.17 M | -$26.46 M | -$18.19 M | -$20.61 M |
| Income Tax Expense | $62.00 K | $63.00 K | $58.00 K | $54.00 K | $59.00 K | $60.00 K |
| Net Income + | $23.52 M | -$154.00 K | -$14.23 M | -$26.51 M | -$18.25 M | -$20.67 M |
| Net Profit Margin | 46.2% | -0.83% | -238.62% | -3998.49% | -177.89% | -1457.4% |
CytomX Therapeutics, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $1.00 K | $2.00 K | $2.00 K | $2.00 K | $2.00 K | $2.00 K |
| Reserve & Surplus | -$668.05 M | -$668.17 M | -$682.33 M | -$711.84 M | -$730.10 M | -$751.06 M |
| Non-Current Liabilities | $23.25 M | $15.92 M | $9.84 M | $5.94 M | $5.39 M | $39.30 M |
| Current Liabilities | $50.20 M | $39.22 M | $41.03 M | $46.62 M | $34.02 M | $39.86 M |
| Total Liabilities | $73.45 M | $55.15 M | $50.87 M | $52.56 M | $39.41 M | $79.16 M |
| Fixed Assets | $2.78 M | $2.46 M | $2.19 M | $1.74 M | $1.49 M | $1.44 M |
| Current Assets | $86.63 M | $164.62 M | $149.22 M | $143.92 M | $353.10 M | $373.15 M |
| Total Assets | $98.50 M | $175.06 M | $158.25 M | $151.57 M | $359.36 M | $381.23 M |
CytomX Therapeutics, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $23.52 M | -$154.00 K | -$14.23 M | -$26.51 M | -$18.25 M | -$20.67 M |
| Operating Cash Flow | -$21.04 M | -$15.75 M | -$15.55 M | -$23.24 M | -$25.55 M | -$18.07 M |
| Investing Cash Flow | $30.60 M | -$76.36 M | $439.00 K | -$14.42 M | -$192.78 M | $5.95 M |
| Financing Cash Flow | $0 | $93.55 M | $253.00 K | $16.64 M | $234.49 M | $511.00 K |
| Change in Cash | $9.55 M | $1.44 M | -$14.86 M | -$21.02 M | $16.16 M | -$11.60 M |
CytomX Therapeutics, Inc. Return Calculator
The CytomX Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$5,373
Invested Amount$10,000
Est. Returns$-4,627
About CytomX Therapeutics, Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
Popular Stocks
FAQs
What is the share price of CytomX Therapeutics, Inc. today?
CytomX Therapeutics, Inc. (CTMX) share price as of September 18, 2026 is $2.81. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of CytomX Therapeutics, Inc.?
Yes, Indian Investors can invest in the CytomX Therapeutics, Inc. (CTMX) Share by opening an international trading account with Angel One.
How can I purchase CytomX Therapeutics, Inc. shares in India?
Purchasing CytomX Therapeutics, Inc. (CTMX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying CytomX Therapeutics, Inc. (CTMX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of CytomX Therapeutics, Inc.?
Yes, you can purchase fractional shares of CytomX Therapeutics, Inc. (CTMX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of CytomX Therapeutics, Inc.?
The market capitalization of CytomX Therapeutics, Inc. on September 18, 2026, is $602.49 M.
In which sector CytomX Therapeutics, Inc. belongs?
CytomX Therapeutics, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in CytomX Therapeutics, Inc. stocks?
In order to invest in CytomX Therapeutics, Inc. (CTMX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
